BIJUVA 1 MG-100 MG CAPSULE
For 30 capsules
Pharmacies pay
$255.95 filed
30 × $8.53176 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-06-01 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$243.27 filed
30 × $8.10884 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
0.95× estimated
Medicare paid about what pharmacies pay.
Part D averages every strength and form sold under “Bijuva” / “Estradiol/Progesterone” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-06-01 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$299.34 estimated
$255.95 + $38.39 (15%) + $5.00 fee per fill = $299.34
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-06-01 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
BIJUVA 1 MG-100 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory does not list its NDC as a package of its own, so OpenBill has no FDA names, dosage form or pharmacologic class for it.
The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 68308-0750-30.
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $255.95 for 30 capsules (30 × $8.53176 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-06-01. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 2, the latest survey was within 2% of the current NADAC, so the NADAC was carried forward from the previous file.
This NDC’s NADAC was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: it took effect on 2026-06-01. The file is new; the price is not.
What NADAC measures · Why 30 capsules · NADAC explanation codes · Carried-forward prices
The NDC
- 68308-0750-30 · not listed as a package in the FDA directory · $8.53176 per EA · eff. 2026-06-01 filed carried forward
What Medicare paid
Medicare Part D paid $243.27 for 30 capsules, at an average of $8.10884 per EA in 2024 (2024-01-01 to 2024-12-31) for “Bijuva” and “Estradiol/Progesterone”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 1,694 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 capsules? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for BIJUVA 1 MG-100 MG CAPSULE labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Bijuva / Estradiol/Progesterone: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.